Background and Objective: High-level gentamicin resistance (HLGR: MIC ≥ 500 µg/ml) in Enterococci is mediated by aminoglycoside modifying enzymes which is mainly encoded by aac(6′)-Ie-aph(2′′)-Ia gene. The aim of this study was to evaluate the frequency of aac(6′)-Ie-aph(2′′)-Ia gene in clinical isolates of Enterococcus facium and Enterococcus faecalis collected from hospitals in northwest of Iran.
INTRODUCTION
Enterococcus (E) faecalis and E. faecium are normal floras of human and animals digestive system, however they are also known as occasional human pathogens responsible for community-acquired and nosocomial infections (1). These bacteria are found in the gastrointestinal and female urinary tracts as part of the normal host flora in healthy individuals where they cause infections (1, 2). Current studies show that these organisms have emerged as a leading cause of nosocomial infections in hospitals. Most of the enterococcal infections are due to E. faecalis isolate. E. faecium is responsible for minority of enterococcal infections (3). Clinical treatments for serious enterococcal infections require a combination of a cell wall active agent and an aminoglycoside, typically gentamicin (4, 5) . Enterococcus species can acquire high-level resistance to a variety of antibiotics by horizontal transfer of mobile genetic determinants, in addition to the intrinsic resistance to several groups of antimicrobials (6).
Resistance to the aminoglycosides usually occurs by enzymatic modification of the antibiotics by aminoglycoside-modifying enzymes (AME) (7). The first case of high-level gentamicin-resistant (HLGR) E. faecalis isolate was reported by Thal and his colleagues (1979) in France (8). Further investigations showed that the reason for high-level resistance to gentamicin antibiotics was due to the fusion of two aminoglycoside-modifying enzyme genes. The resultant bifunctional aac(6′)-aph(2″) aminoglycoside modifying enzyme confers resistance to all clinically useful aminoglycosides except streptomycin. The genes responsible for high-level aminoglycoside resistance have in most cases been identified on plasmids (9). Previous investigations have reported the aac6′-aph2″ gene as being part of a transposable element Tn5281 (10, 11). Association of aac6′-aph2″ with a transposon facilitates rapid distribution of the resistance gene. The aim of this study was to investigate the prevalence of HLGR in clinical isolates of E. faecalis and E. faecium and to determine the molecular basis of the gene responsible for HLGR in these isolates.
MATeRIALS AND MeThODS
Bacterial isolates. A total of 111 Enterococcal isolates were collected from 4 different hospitals in Tabriz, northwest of Iran during July 2009 to August 2011. The identification of the isolates was confirmed with standard biochemical tests. E. faecalis strain HH22, containing the HLGR-conferring transposon Tn5281, and E. faecalis ATTCC 29212 were used as a positive and negative controls, respectively (12). Susceptibility testing. Antibiotic susceptibility was determined by Disc diffusion method (Kirby-Baur) according to the CLSI guidelines (13) . The following antibiotics were tested: streptomycin, erythromycin, ciprofloxacin, nitrofurantoin, ampicillin, tetracycline, penicillin, vancomycin, and gentamicin. 120 μg gentamicin discs (MAST, UK) were used for identification of high level gentamicin resistant strains. The MIC was determined by agar dilution method. Highlevel gentamicin resistance was defined as MIC ≥ 500 µg/ml. Multidrug resistance (MDR) was defined as resistance to three or more antimicrobial classes.
Detection of aac6′-aph2″ by PCR. PCR was performed to amplify the bifunctional aac6′-aph2″ gene sequences. Bacterial cells were lysed and DNA extracted as described by Regnault (14) . Primers 5′CCAAGAGCAATAAGGGCATA3′and 5′CACTATCATAACCACTACCG3′ were used as forward and reverse primers to obtain PCR product of approximately 400 bp. PCR master mix components were as follows; 10X PCR buffer in final concentration of 1X, MgCl 2 (50 mM) in a final concentration of 1.5 mM, dNTP Mix, 10 mM in a final concentration of 0.2 mM and forward and reverse primers in a final concentration of 0.4 μM. PCR amplification was performed in a total volume of 25 μl. Thermal cycling was performed by initial denaturation at 94°C for 4 min followed by 35 cycles of 60 seconds denaturation at 94°C ; 60 seconds annealing at 65°C; 45 seconds extension at 72°C with a final extension at 72°C for 7 minutes. PCR products were analyzed by electrophoresis in 1.2% agarose gel and visualized by gel documentation system (Uvitec, UK) after staining with ethidium bromide (15).
Plasmid extraction. For isolation of plasmid harboring Tn528 transposone, all isolates that were positive for aac6′-aph2″ gene subjected to plasmid extraction following the method described by Woodford et al (16) .
Long PCR. To identify the isolates containing Tn5281 transposone, a long PCR was carried out with a single primer 5'-CAGAACAGCTGGATCCTATGG-3' using plasmid extracts as templates. The reaction mixture for long PCR was prepared according to the instructions of manufacturer (Roche diagnostics, Germany). The thermal cycling for amplification of Tn5281 transposone has shown in Table1. Products were analyzed by gel electrophoresis and photographed to determine the 3.4 Kb product. Dot-Blot hybridization. Dot-Blot hybridization method was performed to determine the presence of aac(6′)-aph(2′′) gene on Tn5281 transposone. 1 μg of plasmid extracts was dissolved in double distilled water to a final volume of 16 μl and denaturized by heating in a boiling water bath for 10 minutes. 4 μl of digoxigenin labeled aac(6′)-aph(2′′) PCR product was mixed with denaturized plasmid and the mixture was incubated for 1 h at 37°C. Finally the reaction was stopped by adding 2 μl of 200mM EDTA. A serial dilution of hybridization reactions were applied to a positively charged nylon membrane. Part of the nylon membrane was preloaded with defined dilutions of labeled control DNA which were used as standard. The nylon membrane was subjected to immunological detection with anti-digoxigenin antibody. The intensities of hybridization products and control DNA were compared by exposure to imaging device (17).
ReSULTS
Patients and specimens. In this study, 193 clinical specimens from 90 in-patients and 103 out-patients were collected. A total of 111 Enterococci isolates were isolated from 45 in-patients and 66 outpatients. The origin of isolates has shown in Fig. 1 
DISCUSSION
In recent decades enterococci have emerged as a highly important nosocomial and communityacquired pathogens. Although these bacteria are generally thought to be a low virulence pathogen, it is now unveiled that these organisms can cause serious invasive infections, including endocarditis, bacteremia, urinary tract and pelvic infections. The role of enterococci as a causative agent of various infections has become considerably important, not only for their documented pathogenic potential but also due to increasing antimicrobial resistance (especially resistance to glycopeptides) in most of isolates (18). Aminoglycosides are frequently used in combination with cell wall active antibiotics for severe enterococcal infections. It has shown that the cell wall active agents disrupt the bacterial cell wall to allow the aminoglycoside to enter and exert their bactericidal effects (19, 20) . Low-level aminoglycoside resistance is an intrinsic characteristic in all enterococcal species. However, acquired high-level aminoglycoside resistance may be caused by various aminoglycoside-modifying enzymes (19, 20) . Several studies demonstrated that aminoglycoside high-level resistance genes in enterococci are encoded on plasmids, conjugative elements, or the most commonly on conjugative transposons, that mediate the horizontal transfer of resistance determinants (9, 18, 19) .
In our study, high-level resistance to gentamicin was observed in 32.43% of isolated enterococci. This frequency is lower than the rates reported by Dadfarma (57.4%, 2010) (24) and Feizabadi (65%, (Table  2) . Multidrug resistance was observed in 49.09% of isolates which is a high rate in comparison to other studies carried out in recent years (18) (19) (20) .
Resistance to aminoglycosides usually occurs by enzymatic modification of drugs by aminoglycoside modifying enzymes which are carried on mobile elements such as transposons. The results of this study showed that 88% of HLGR isolates contained Tn5281 among them 94% of isolates carried aac(6′)-Ie-aph(2′′)-Ia resistance gene. These findings are consistent with previous report on carriage of HLGR genes on transposons in enterococcus species (18, 19) . This finding suggests that aminoglycoside resistance genes are possibly disseminated through the population of enterococci species by Tn5281.
In conclusion, the results of this study revealed high prevalence of HLGR genes among enterococcal isolates in the study region. The carriage of resistance gene on mobile element Tn5281 reminded the possibility of dissemination of HLGR among different pathogenic bacteria.
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ReFeReNCeS
positive clinical isolates; Lane 3: positive control (E. faecalis HH22); lane 7: negative control (E. faecalis ATCC29212). Dot-Blot hybridization of 32 HLGR isolates; P: positive control (E. faecalis HH22); N : negative control ( E.faecalis ATCC29212); Dots 1 to 32: HLGR isolates. 
